Serum lipid peroxides and magnesium levels following three months of treatment with pioglitazone in patients with Type 2 Diabetes mellitus

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 7, Issue 1, 2013, Pages 35-37

  Niranjan, G ^a   Mohanavalli, V ^a   Srinivasan, A R ^a   Ramesh, R ^a  

^a MAHATMA GANDHI MEDICAL COLLEGE AND RESEARCH INSTITUTE   (India)

Author keywords

Magnesium; Malondialdehyde; Pioglitazone; Type 2 Diabetes mellitus

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CREATININE; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN A1C; LIPID PEROXIDE; MAGNESIUM; MALONALDEHYDE; PIOGLITAZONE; SULFONYLUREA; UREA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DRUG SAFETY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; UREA BLOOD LEVEL;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INDIA; KIDNEY; LIPID PEROXIDATION; LIPID PEROXIDES; MAGNESIUM; MALE; MIDDLE AGED; OXIDATIVE STRESS; RENAL TUBULAR TRANSPORT, INBORN ERRORS; THIAZOLIDINEDIONES;

EID: 84875364620     PISSN: 18714021     EISSN: 18780334     Source Type: Journal    
DOI: 10.1016/j.dsx.2013.02.020     Document Type: Article

References (30)

1. H. King, R.E. Aubert, and W.H. Herman Global burden of diabetes, 1995-2025: prevalence, numerical estimates and projections Diabetes Care 21 9 1998 1414 1431
2. A.A. Khaled, M. Sekaran, and S.I. Ikram Type 2 Diabetes and vascular complications: a pathophysiologic view Biomedical Research 21 2 2010 147 155
3. J.C. Parker Troglitazone: the discovery and development of a novel therapy for the treatment of type 2 diabetes mellitus Advanced Drug Delivery Reviews 54 9 2002 1173 1197
4. F. Ovalle, and D.S. Bell Clinical evidence of thiazolidinedione-induced improvement of pancreatic beta-cell function in patients with type 2 diabetes mellitus Diabetes, Obesity and Metabolism 4 1 2002 56 59
5. N.M. Jason, and J.S. Baerlocher Management of type 2 diabetes mellitus, role of thiazolidinediones Canadian Family Physician 51 2005 683 687
6. M.P. Singh, D. Pathak, G.K. Sharma, and C.S. Sharma Peroxisome proliferator-activated receptors (PPARS): a target with a broad therapeutic potential for human diseases: an overview Pharmacologyonline 2 2011 58 89
7. P. de Pablos-Velasco Pioglitazone: beyond glucose control British Journal of Pharmacology 160 8 2010 1889 1891
8. C. Dominguez, E. Ruiz, M. Gussinye, and A. Carrascosa Oxidative stress at onset and in early stages of type I diabetes in children and adolescents Diabetes Care 21 10 1998 1736 1742
9. J.W. Baynes Role of oxidative stress in development of complications in diabetes Diabetes 40 4 1991 405 412
10. J.L. Skibba, R.H. Powers, A. Stadnicka, D.W. Cullinane, U.A. Almagro, and Kalbfleisch JH Oxidative stress as a precursor to the irreversible hepatocellular injury caused by hyperthermia International Journal of Hyperthermia 7 5 1991 749 761
11. C.H. Sales, and L.deF. Campos Pedrosa Magnesium and diabetes mellitus: their relation Clinical Nutrition 25 2006 554 562
12. L.R. Ruy, C.W. Walter, B.R. Eric, L. Simin, J.S. Meir, and E.M. Joann Magnesium intake and risk of type 2 diabetes in men and women Diabetes Care 27 1 2004 134 140
13. L. Tosiello Hypomagnesemia and diabetes mellitus. A review of clinical implications Archives of Internal Medicine 156 11 1996 1143 1148
14. H. Nasri, and H.R. Baradaran Lipids in association with serum magnesium in diabetes mellitus patients Bratislavske Lekarske Listy 109 7 2008 302 306
15. V. Kuzhandaivelu, B. Jyothirmayi, and J.S. Kumar Insulin resistance and alanine amino transaminase levels in first degree relatives of type 2 diabetes mellitus Diabetes, Metabolic Syndrome 5 3 2011 143 147
16. K.G. Tolman, J.W. Freston, S. Kupfer, and A. Perez Liver safety in patients with type 2 diabetes treated with pioglitazone: results from a 3-year, randomized, comparator-controlled study in the US Drug Safety 32 9 2009 787 800
17. M. Emdin, A. Pompella, and A. Paolicchi Gamma glutamyl transferase atherosclerosis and cardiovascular disease: triggering within the plaque Circulation 112 2005 2078 2080
18. N. Gopal, A. Selvam, A.R. Srinivasan, S. Saha, and P.H. Muddegowda Serum gamma glutamyl tranferase levels in obese South Indian adults with reference to atherogenic lipid risk factors and lipid peroxides International Journal of Medical Science 1 2 2012 35 42
19. P. Shah, and S. Mudaliar Pioglitazone: side effect and safety profile Expert Opinion on Drug Safety 9 March (2) 2010 347 354
20. G.F. Lewis, A. Carpentier, K. Adeli, and A. Giacca Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes Endocrine Reviews 23 2 2002 201 229
21. R.D. Ankush, A.N. Suryakar, and N.R. Ankush Hypomagnesaemia in type 2 diabetes mellitus patients: a study on the status of oxidative and nitrosative stress Indian Journal of Clinical Biochemistry 24 2 2009 184 189
22. B. Sung, S. Park, B.P. Yu, and H.Y. Chung Amelioration of age-related inflammation and oxidative stress by PPARγ activator: Suppression of NF-κB by 2,4-thiazolidinedione Experimental Gerontology 41 6 2006 590 599
23. M.G. Pavlatou, M. Papastamataki, F. Apostolakou, I. Papassotiriou, and N. Tentolouris FORT and FORD: two simple and rapid assays in the evaluation of oxidative stress in patients with type 2 diabetes mellitus Metabolism: Clinical and Experimental 58 11 2009 1657 1662
24. N. Singhania, D. Puri, S.V. Madhu, and S.B. Sharma Assessment of oxidative stress and endothelial dysfunction in Asian Indians with type 2 diabetes mellitus with and without macroangiopathy QJM 101 6 2008 449 455
25. M.L. Jürgen, B.M. Linda, A.S.O. Tracey, O.W. William, and A.K. Steven An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ) Journal of Biological Chemistry 270 22 1995 12953 12956
26. D.D. Sears, A. Hsiao, and J.M. Ofrecio Selective modulation of promoter recruitment and transcriptional activity of PPARγ Biochemical and Biophysical Research Communications 364 2007 515 521
27. C. Massimo, A. Manuela, C. Sara, M. Gianluca, and T. Chiara Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation British Journal of Pharmacology 160 2010 1892 1902
28. B. Mandeep, B. Rais, S. Swangjit, J.H. Lou, K.C. Dawn, and W.C. Gary Effects of pioglitazone on intramyocellular fat metabolism in patients with type 2 diabetes mellitus Journal of Clinical Endocrinology and Metabolism 95 2010 1916 1923
29. B. Gross, and B. Staels PPAR agonists: multimodal drugs for the treatment of type 2 diabetes Best Practice and Research in Clinical Endocrinology and Metabolism 21 4 2007 687 710
30. H.H. Elizabeth Elevated liver function tests in type 2 diabetes Clinical Diabetes 23 3 2005 115 119